Research Library, Research Protocols

BPC-157 Research Guide: Mechanism, Studies & Reconstitution

Research Use Only Disclaimer: All content on this page is intended strictly for educational and research purposes. The compounds discussed are not approved by the FDA for human use and are not intended to diagnose, treat, cure, or prevent any disease or condition. For in vitro and preclinical research use only.

What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective gastric protein. Composed of 15 amino acids, it has been the subject of extensive preclinical research due to its apparent role in tissue repair, angiogenesis, and cytoprotection across multiple organ systems.

Molecular Profile

  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • Molecular weight: 1,419.5 g/mol
  • CAS number: 137525-51-0
  • Solubility: Water-soluble; reconstitute with bacteriostatic water

Research Overview

Preclinical studies involving BPC-157 have investigated its effects across several biological systems:

Tendon & Musculoskeletal Research

Multiple rodent studies have reported accelerated tendon-to-bone healing and improved collagen organization in surgically transected tendons following BPC-157 administration. Researchers have observed upregulation of growth hormone receptors in fibroblast populations as a proposed mechanism.

Gastrointestinal Research

BPC-157 has been widely studied in GI models, including NSAID-induced ulceration and inflammatory bowel disease models. Studies suggest modulation of the nitric oxide system and promotion of mucosal healing as key investigative targets.

Neuroprotective Research

Emerging preclinical data has examined BPC-157 in traumatic brain injury and dopamine-system models, with researchers noting potential interactions with serotonergic and dopaminergic signaling pathways.

Reconstitution Protocol (Research Reference)

  1. Allow the lyophilized vial to reach room temperature before opening.
  2. Using a sterile syringe, inject bacteriostatic water slowly down the inside wall of the vial — do not inject directly onto the powder.
  3. Gently swirl (do not shake) until fully dissolved. The solution should be clear and colorless.
  4. Standard research dilution: add 2ml bacteriostatic water to a 5mg vial for a concentration of 2,500mcg/ml.
  5. Store reconstituted peptide at 2–8°C (refrigerated). Use within 28 days.

Storage Guidelines

  • Lyophilized (dry): Store at -20°C to -80°C for long-term; 2–8°C for short-term (up to 3 months).
  • Reconstituted: Refrigerate at 2–8°C. Do not freeze reconstituted solution.
  • Protect from light and moisture.
Research Use Only Disclaimer: All content on this page is intended strictly for educational and research purposes. The compounds discussed are not approved by the FDA for human use and are not intended to diagnose, treat, cure, or prevent any disease or condition. For in vitro and preclinical research use only.

References

  1. Sikiric P, et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” Current Neuropharmacology. 2016.
  2. Chang CH, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of Applied Physiology. 2011.
  3. Gwyer D, et al. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and Tissue Research. 2019.

Leave a Reply

Your email address will not be published. Required fields are marked *